PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.\', \'LUMC Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Internal Medicine, Division of Nephrology, Amphia Hospital, Breda, The Netherlands.\', \'Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Surgery, Division of Transplantation Surgery, Leiden University Medical Center, Leiden, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ajt.15943
?:doi
?:hasPublicationType
?:journal
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
is ?:pmid of
?:pmid
?:pmid
  • 32337790
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all